Skip to content

The Effect of Different Oxygen Therapies on respiration in Obese Patients After Extubation

The Impact of Different Oxygen Therapies on Oxygenation and Postoperative Pulmonary Complications in Obese Patients After Extubation of General Anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097334
Enrollment
Unknown
Registered
2025-02-18
Start date
2024-06-03
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I. Occurrence of pulmonary complications within 7 days postoperatively (including any pleural effusion, pulmonary edema, pulmonary embolism, pneumonia, acute respiratory distress syndrome, bronchospasm, aspiration, pneumothorax. Mainly determined by the patient's discharge diagnosis and other medical documents) II. Oxygenation status: 1) Poor oxygen therapy effect: ? Decline in oxygen saturation

Interventions

HFNC group:high-flow nasal cannula oxygen therapy, HFNC
COT group:conventional oxygen therapy, COT

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old, ASA assessed the patients with grade I to III under general anesthesia; 2. 28.0 kg/m^2<=BMI<35.0kg/m^2; 3.Volunteer to participate in the study and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1.There are respiratory diseases that may require continuous oxygen therapy before surgery, such as COPD, pulmonary infection, pneumothorax, atelectasis, asthma, etc; 2.Patients with a history of mental disorders or inability to communicate; 3.HFNC contraindication: upper respiratory tract complete obstruction or nasal obstruction; Any history of nasal/facial defects that may prevent the use of HFNC or the mask; 4.There are electrical impedance tomography (EIT) monitoring contraindos: chest circumference >150cm and can not use the EIT belt; Implantation of a pacemaker, defibrillator or other device that may interfere with electrical impedance measurements; There are wounds or dressings in the EIT wearing area.

Design outcomes

Primary

MeasureTime frame
PaO2/FiO2;

Secondary

MeasureTime frame
Systolic Blood Pressure (SBP);Heart rate (HR);Respiratory rate;Pulse oxygen saturation;Respiratory mechanics related indicators;Lung function assessment;Diastolic Blood Pressure (DBP);Mean Blood Pressure (MBP);Visual Analogue Scale assessment;Lung Ultrasound Score assessment (LUS score);the incidence of pulmonary complications within 7 days postoperatively;Richmond Agitation-Sedation Scale(RASS);visual analog scale(VAS);the incidence rate of acute respiratory system events during oxygen therapy;hospital stay duration;whether transferred to the ICU;the duration of ICU stay;

Countries

China

Contacts

Public ContactWu Jing

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

drjingwu@hust.edu.cn+86 13995650750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026